High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2760-2764

  Janoir, Claire ^a   Zeller, Valérie ^a   Kitzis, Marie Dominique ^b   Moreau, Nicole J ^a   Gutmann, Laurent ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CELL TRANSFORMATION; DRUG ACCUMULATION; DRUG SENSITIVITY; GENE EXPRESSION REGULATION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0029852080     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2760     Document Type: Article

References (40)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Belland, R. J., S. G. Morrison, C. Ison, and W. M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
3. Bernard, L., J.-C. Nguyen Van, and J.-L. Mainardi. 1994. In vivo selection of Streptococcus pneumoniae, resistant to quinolones, including sparfloxacin. Clin. Microbiol. Infect. 1:60-61.
4. Brockbank, S. M. V., and P. T. Barth. 1993. Cloning, sequencing, and expression of the DNA gyrase genes from Staphylococcus aureus. J. Bacteriol. 175:3269-3277.
5. Cambau, E., and L. Gutmann. 1993. Mechanisms of resistance to quinolones. Drugs 45(Suppl. 3):15-23.
6. Canton, E., J. Peman, M. T. Jimenez, M. S. Ramon, and M. Gobernado. 1992. In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrob. Agents Chemother. 36:558-565.
7. Cooper, M. A., J. M. Andrews, J. P. Ashby, R. S. Matthews, and R. Wise. 1990. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. J. Antimicrob. Chemother. 26:667-676.
8. Deguchi, T., M. Yasuda, M. Asano, K. Tada, H. Iwata, H. Komeda, T. Ezaki, I. Saito, and Y. Kawada. 1995. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 39:561-563.
9. Denis, A., and N. J. Moreau. 1993. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition. J. Antimicrob. Chemother. 32:379-392.
10. Fernandes, C. J., and V. P. Ackerman. 1990. In vitro studies of ciprofloxacin and survey of resistance patterns in current isolates. Diagn. Microbiol. Infect. Dis. 13:79-91.
11. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
12. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
13. Goswitz, J. J., K. E. Willard, C. E. Fasching, and L. R. Peterson. 1992. Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrob. Agents Chemother. 36:1166-1169.
14. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.
15. Hooper, D. C., J. S. Wolfson, K. S. Souza, C. Tung, G. L. McHugh, and M. N. Swartz. 1986. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob. Agents Chemother. 29:639-644.
16. Ito, H., H. Yoshida, M. Bogaki-Shonai, T. Niga, H. Hattori, and S. Nakamura. 1994. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob. Agents Chemother. 38: 2014-2023.
17. Kaatz, G. W., S. M. Seo, and C. A. Ruble. 1991. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J. Infect. Dis. 163:1080-1086.
18. Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
19. Korten, V., W. M. Huang, and B. E. Murray. 1994. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis. Antimicrob. Agents Chemother. 38:2091-2094.
20. Lacks, S., and R. D. Hotchkiss. 1960. A study of the genetic material determining an enzyme activity in Pneumococcus. Biochim. Biophys. Acta 39:508-518.
21. Lafredo, S. C., B. D. Foleno, and K. P. Fu. 1993. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro. Chemotherapy (Basel) 39:36-39.
22. Laible, G., R. Hakenbeck, M. A. Sicard, B. Joris, and J.-M. Ghuysen. 1989. Nucleotide sequences of the pbpX genes encoding the penicillin-binding proteins 2x from Streptococcus pneumoniae R6 and a cefotaxime-resistant mutant, C506. Mol. Microbiol. 3:1337-1348.
23. Lefevre, J. C., J. P. Claverys, and A. M. Sicard. 1979. Donor deoxyribonucleic acid length and marker effect in pneumococcal transformation. J. Bacteriol. 138:80-86.
24. Malmborg, A.-S., and S. Ahlén. 1993. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens. Chemotherapy (Basel) 39:32-35.
25. Margerrison, E. E. C., R. Hopewell, and L. M. Fisher. 1992. Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins. J. Bacteriol. 174:1596-1603.
26. Muñoz, R., M. Bustamante, and A. G. de la Campa. 1995. Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance. J. Bacteriol. 177:4166-4170.
27. Ottolengni, E., and R. D. Hotchkiss. 1962. Release of genetic transforming agent from pneumococcal cultures during growth and disintegration. J. Exp. Med. 116:491-519.
28. Pan, X.-S., and L. M. Fisher. 1996. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J. Bacteriol. 178:4060-4069.
29. Pérez-Trallero, E., J. M. Garcia-Arenzana, J. A. Jimenez, and A. Peris. 1990. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 9:905-906.
30. Piddock, L. J. V., and R. Wise. 1988. The selection and frequency of streptococci with decreased susceptibility to ofloxacin compared with other quinolones. J. Antimicrob. Chemother. 22(Suppl. C):45-51.
31. Sreedharan, S., L. R. Peterson, and L. M. Fisher. 1991. Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 35:2151-2154.
32. Takenouchi, T., C. Ishii, M. Sugawara, Y. Tokue, and S. Ohya. 1995. Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones. Antimicrob. Agents Chemother. 39:1414-1418.
33. Tankovic, J., E. Derlot, J. Duval, and P. Courvalin. 1994. A mutation in the gyrase A gene of Streptococcus pneumoniae BM4201 is associated with sparfloxacin resistance in a single-step in vitro mutant, abstr. 25/C3. In 15th Interdisciplinary Meeting on Anti-Infectious Chemotherapy, Paris, France.
34. Thomson, K. S., and C. C. Sanders. 1994. Dissociated resistance among fluoroquinolones. Antimicrob. Agents Chemother. 38:2095-2100.
35. Thys, J. P., F. Jacobs, and B. Byl. 1991. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 10:304-315.
36. Tiraby, J.-G., and M. S. Fox. 1973. Marker discrimination in transformation and mutation of Pneumococcus. Proc. Natl. Acad. Sci. USA 70:3541-3545.
37. Yamagishi, J., H. Yoshida, M. Yamayoshi, and S. Nakamura. 1986. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol. Gen. Genet. 204:367-373.
38. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
39. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.
40. Yoshida, H., T. Kojima, J. Yamagishi, and S. Nakamura. 1988. Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol. Gen. Genet. 211:1-7.